In Vivo Emergence of Resistance to Novel Cephalosporin-β-Lactamase Inhibitor Combinations through the Duplication of Amino Acid D149 from OXA-2 β-Lactamase (OXA-539) in Sequence Type 235 Pseudomonas aeruginosa.
about
Genomics and Susceptibility Profiles of Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa from Spain.Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa.The Versatile Mutational Resistome of Pseudomonas aeruginosa.Failure of ceftolozane‐tazobactam salvage therapy in complicated pneumonia with lung abscess.
P2860
In Vivo Emergence of Resistance to Novel Cephalosporin-β-Lactamase Inhibitor Combinations through the Duplication of Amino Acid D149 from OXA-2 β-Lactamase (OXA-539) in Sequence Type 235 Pseudomonas aeruginosa.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
In Vivo Emergence of Resistanc ...... pe 235 Pseudomonas aeruginosa.
@en
type
label
In Vivo Emergence of Resistanc ...... pe 235 Pseudomonas aeruginosa.
@en
prefLabel
In Vivo Emergence of Resistanc ...... pe 235 Pseudomonas aeruginosa.
@en
P2093
P2860
P50
P356
P1476
In Vivo Emergence of Resistanc ...... ype 235 Pseudomonas aeruginosa
@en
P2093
Ester Del Barrio-Tofiño
José L Pérez
Pablo A Fraile-Ribot
Xavier Mulet
P2860
P356
10.1128/AAC.01117-17
P407
P577
2017-08-24T00:00:00Z